摘要 |
<p>The present invention relates to novel heterocyclic compounds as diacylglycerol acyltransferase ("DGAT") inhibitors, pharmaceutical compositions comprising the heterocyclic compounds and the use of the compounds for treating or preventing a cardiovascular disease, a metabolic disorder, obesity or an obesity-related disorder, diabetes, dyslipidemia, a diabetic complication, impaired glucose tolerance or impaired fasting glucose. An illustrative compound of the invention is shown below (I).</p> |
申请人 |
SCHERING CORPORATION;ZHOU, GANG;WISHART, GRANT;TING, PAULINE, C.;ASLANIAN, ROBERT, G.;ZORN, NICOLAS;CAO, JIANHUA |
发明人 |
ZHOU, GANG;WISHART, GRANT;TING, PAULINE, C.;ASLANIAN, ROBERT, G.;ZORN, NICOLAS;CAO, JIANHUA |